摘要
目的:改进沙格列汀的合成路线。方法:以(S)-N-叔丁氧羰基-(3-羟基金刚烷-1-基)甘氨酸和2,2'-二硫化二苯并噻唑为原料,在亚磷酸三乙酯的还原作用下生成(S)-N-叔丁氧羰基-(3-羟基金刚烷-1-基)甘氨酸苯并[d]噻唑-2-硫酯;该硫醇活性酯与(1S,3S,5S)-2-氮杂双环[3.1.0]己烷-3-甲腈对甲苯磺酸盐发生缩合反应,再经盐酸脱氨基保护基等步骤得到抗糖尿病药物沙格列汀。结果:所得目标产物总收率35.6%,产品纯度在99.9%以上。结论:改进后的工艺操作简单,产率较高,产品纯度高,适合工业化生产。
Objective: To improve the synthetic route of saxagliptin. Methods: Starting from (S)-N- (t-butoxycarbonyl) -3-hydroxyadamantylglycine and 2,2 '-dithiobis ( benzothiazole ) , ( S ) -N-( t-butoxycarbonyl ) -3- hydroxyadamantylglycine 2-benzol d] thiazolyl thioester was obtained under the reduction of triethyl phosphite. The active thioester was reacted with ( 1 S, 3S, 5S) -2-azabicyclo [ 3. 1.0 ] hexane-3-carbonitrile methanesulfonate, and then it was subjected to hydrochloride to deprotect the amino protecting group to give the antidiabetic agent saxagliptin. Results: Saxagliptin was synthesized with a total yield of 35.6% , and the product purity was more than 99.9% as determined by HPLC. Conclusion: The improved synthetic process, with simplified operation, good yield and high purity, is applicable for industrial production.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2018年第2期203-206,共4页
Chinese Journal of New Drugs